Interestingly, the delivery in this mouse model of anti-CSF1R antibodies, which depletes monocytes by inducing apoptosis and blocking their differentiation to macrophages, along with the tyrosine kinase inhibitor nilotinib, significantly increased the overall survival of leukemia-transplanted mice [111]. The gene discussed is CSF1R; the disease is leukemia.